Holen Sie sich die Stockscreener-App
26.85
2.96%
-0.82
Handel nachbörslich:
26.85
Artivion Inc Aktie (AORT) Neueste Nachrichten
Artivion Inc (AORT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Artivion Market Sentiment - Benzinga España
Artivion Inc (AORT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Artivion Inc (AORT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
AORT|Artivion Inc|Price:25.280|Chg%:+0.280 - TradingKey
Artivion Inc (AORT) Balance Sheet - TradingKey
Artivion, Inc. Revenue Breakdown – SWB:CYL - TradingView
AORT|Artivion Inc|Price:26.100|Chg%:+0.820 - TradingKey
Artivion, Inc. (AORT) stock price, news, quote and history - Yahoo Finance UK
Artivion, Inc. Revenue Breakdown – LS:900006 - TradingView
Artivion Inc (AORT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Artivion schedules Q2 results webcast for Aug. 6 at 4:30 p.m. - Stock Titan
Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2026 Financial Results - TradingView
Artivion Inc (AORT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Artivion (AORT) Grew in Q1, but AMDS Timing and Lower 2026 Targets Still Softened the Story - AlphaStreet
Below Expected Sales for AMDS Hurt Artivion (AORT) in Q2 - Yahoo Finance
Citizens reiterates Artivion stock rating citing FDA approval benefits By Investing.com - Investing.com South Africa
Citizens reiterates Artivion stock rating citing FDA approval benefits - Investing.com
Needham reiterates Artivion stock rating on product cycle outlook By Investing.com - Investing.com Nigeria
Needham reiterates Artivion stock rating on product cycle outlook - Investing.com
Artivion (AORT) Corporate presentation Summary - Quartr
Artivion, Inc. (AORT) Stock Live Price, Chart & News - CoinCodex
Artivion, Inc. (AORT) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
AORT Q1 2026 Earnings: EPS Misses Estimates, Stock Edges LowerDividend Growth Analysis - Bölüm Sonu Canavarı
Artivion (AORT) Stifel 2025 Healthcare Conference Summary - Quartr
Artivion (AORT) Is Up 10.1% After Full FDA PMA Approval for AMDS Aortic Device - simplywall.st
What Boosted Artivion (NYSE:AORT) Following FDA PMA Approval? - Kalkine Media
Artivion seeks to tap $150 million US market opportunity with FDA approval - MSN
Artivion stock gets FDA approval for NEXUS stent graft system By Investing.com - Investing.com India
Artivion (AORT) Stock Forum and Discussion - Moomoo
AORTArtivion Inc Options - Finviz
Artivion raises 2025 revenue guidance to $435M–$443M as On-X and stent grafts drive double-digit growth - MSN
Artivion Secures FDA Approval for AMDS Hybrid Prosthesis Device - Yahoo Finance
Artivion: PMA Approval Supports Accelerating Growth And Margin Expansion (NYSE:AORT) - Seeking Alpha
Artivion stock rises after FDA approves AMDS device - Investing.com
Enterprise value to revenue forward of Artivion, Inc. – SWB:CYL - TradingView
Canaccord reiterates Artivion stock rating on FDA approval By Investing.com - Investing.com South Africa
Artivion (AORT) Secures FDA Approval for AMDS Hybrid Prosthesis - GuruFocus
Artivion Seeks To Tap $150 Million US Market Opportunity With FDA Approval - Benzinga
Why Artivion (AORT) Is Up 17.3% After Full FDA PMA Approval for AMDS Hybrid Prosthesis - simplywall.st
Artivion receives FDA PMA approval for AMDS Hybrid Prosthesis in aortic dissections - grafa.com
Canaccord reiterates Artivion stock rating on FDA approval - Investing.com
Artivion Shares Rise After FDA Approves AMDS Aortic Device - TradingPedia
Artivion Wins FDA Nod for AMDS Hybrid Prosthesis - Medical Product Outsourcing
Artivion stock rises after FDA approves AMDS device By Investing.com - Investing.com Canada
Artivion, Inc.(NYSE: AORT) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
Artivion's Hybrid Prosthesis Device Gets FDA Premarket Approval; Shares Up Pre-Bell - Moomoo
Artivion receives FDA approval for aortic dissection device By Investing.com - Investing.com South Africa
Artivion receives FDA approval for aortic dissection device - Investing.com
1.04%
11.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):